LT2809320T - (1r,4r)-6`-fluor-(n-metil- arba n,n-dimetil-)-4-fenil-4`,9`-dihidro-3`h-spiro-[cikloheksan-1,1`-pirano[3,4,b]indol]-4-aminas fibromialgijos ir lėtinio nuovargio sindromo gydymui - Google Patents

(1r,4r)-6`-fluor-(n-metil- arba n,n-dimetil-)-4-fenil-4`,9`-dihidro-3`h-spiro-[cikloheksan-1,1`-pirano[3,4,b]indol]-4-aminas fibromialgijos ir lėtinio nuovargio sindromo gydymui

Info

Publication number
LT2809320T
LT2809320T LTEP13701807.3T LT13701807T LT2809320T LT 2809320 T LT2809320 T LT 2809320T LT 13701807 T LT13701807 T LT 13701807T LT 2809320 T LT2809320 T LT 2809320T
Authority
LT
Lithuania
Prior art keywords
pyrano
indol
spiro
dihydro
cyclohexane
Prior art date
Application number
LTEP13701807.3T
Other languages
English (en)
Inventor
Stefanie Frosch
Klaus Linz
Petra Bloms-Funke
Original Assignee
Grünenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grünenthal GmbH filed Critical Grünenthal GmbH
Publication of LT2809320T publication Critical patent/LT2809320T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
LTEP13701807.3T 2012-02-03 2013-02-01 (1r,4r)-6`-fluor-(n-metil- arba n,n-dimetil-)-4-fenil-4`,9`-dihidro-3`h-spiro-[cikloheksan-1,1`-pirano[3,4,b]indol]-4-aminas fibromialgijos ir lėtinio nuovargio sindromo gydymui LT2809320T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12000743 2012-02-03
PCT/EP2013/051979 WO2013113857A1 (en) 2012-02-03 2013-02-01 (1r,4r)-6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro-[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for treating fibromyalgia and chronic fatigue syndrome

Publications (1)

Publication Number Publication Date
LT2809320T true LT2809320T (lt) 2017-05-25

Family

ID=47628188

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP13701807.3T LT2809320T (lt) 2012-02-03 2013-02-01 (1r,4r)-6`-fluor-(n-metil- arba n,n-dimetil-)-4-fenil-4`,9`-dihidro-3`h-spiro-[cikloheksan-1,1`-pirano[3,4,b]indol]-4-aminas fibromialgijos ir lėtinio nuovargio sindromo gydymui

Country Status (24)

Country Link
US (1) US20130202701A1 (lt)
EP (1) EP2809320B1 (lt)
JP (1) JP6126134B2 (lt)
KR (1) KR102061482B1 (lt)
CN (1) CN104168897B (lt)
AU (1) AU2013214223B2 (lt)
BR (1) BR112014019136A8 (lt)
CA (1) CA2863572C (lt)
CY (1) CY1118799T1 (lt)
DK (1) DK2809320T3 (lt)
EA (1) EA025500B1 (lt)
ES (1) ES2629211T3 (lt)
HK (1) HK1199218A1 (lt)
HR (1) HRP20170581T1 (lt)
IL (1) IL233871B (lt)
LT (1) LT2809320T (lt)
MX (1) MX353740B (lt)
NZ (1) NZ629800A (lt)
PL (1) PL2809320T3 (lt)
PT (1) PT2809320T (lt)
RS (1) RS56097B1 (lt)
SI (1) SI2809320T1 (lt)
WO (1) WO2013113857A1 (lt)
ZA (1) ZA201406447B (lt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3247352T3 (da) 2015-01-23 2020-09-07 Gruenenthal Gmbh Cebranopadol til behandling af smerter hos individer med forringet lever- og/eller forringet nyrefunktion

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900420A (en) * 1997-06-19 1999-05-04 Cole; William L. Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
DE10252667A1 (de) 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE10360792A1 (de) * 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
WO2005092858A2 (en) * 2004-03-29 2005-10-06 Pfizer Japan Inc. Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
KR20090015089A (ko) * 2006-05-31 2009-02-11 세프라코 아이엔시. 트랜스 4-(3,4-디클로로페닐)-1,2,3,4-테트라하이드로-1-나프탈렌아민 및 그의 포름아미드에 의한 통증장애 치료방법
DE102006046745A1 (de) * 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz

Also Published As

Publication number Publication date
HK1199218A1 (en) 2015-06-26
BR112014019136A2 (lt) 2017-06-20
CN104168897A (zh) 2014-11-26
EP2809320A1 (en) 2014-12-10
US20130202701A1 (en) 2013-08-08
DK2809320T3 (en) 2017-05-15
CA2863572C (en) 2019-08-27
EA025500B1 (ru) 2016-12-30
NZ629800A (en) 2016-06-24
SI2809320T1 (sl) 2017-07-31
AU2013214223B2 (en) 2017-03-23
MX353740B (es) 2018-01-26
AU2013214223A1 (en) 2014-09-18
IL233871B (en) 2018-06-28
IL233871A0 (en) 2014-09-30
CN104168897B (zh) 2016-09-28
MX2014008865A (es) 2014-08-27
ES2629211T3 (es) 2017-08-07
KR20140130695A (ko) 2014-11-11
JP6126134B2 (ja) 2017-05-10
RS56097B1 (sr) 2017-10-31
WO2013113857A1 (en) 2013-08-08
HRP20170581T1 (hr) 2017-06-16
PL2809320T3 (pl) 2017-09-29
CY1118799T1 (el) 2018-01-10
JP2015505553A (ja) 2015-02-23
ZA201406447B (en) 2016-02-24
EA201400857A1 (ru) 2015-01-30
BR112014019136A8 (pt) 2017-07-11
KR102061482B1 (ko) 2020-01-03
CA2863572A1 (en) 2013-08-08
PT2809320T (pt) 2017-06-30
EP2809320B1 (en) 2017-03-22

Similar Documents

Publication Publication Date Title
ZA201504401B (en) Filter arrangements; components; assemblies; and, methods
EP2728157A4 (en) ADSORPTIONANTS FOR CANISTERS AND CANISTERS
ZA201308395B (en) Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/orbace2 inhibitors
PL2931417T3 (pl) Adsorbenty zeolitowe i ich zastosowanie
GB2492155B (en) Devices and methods for emanating liquids
EP2800717A4 (en) ELEVATOR ARRANGEMENT AND METHOD FOR REPLACING THE ELEVATOR ARRANGEMENT
ZA201400028B (en) Devices and methods for emanating liquids
EP2827684A4 (en) LIGHTING DEVICE AND ILLUMINATION METHOD
SG11201404609XA (en) Agent for improving aroma intensity and/or aroma quality
IL233055A0 (en) (1r,r4) 7-oxo-2-azabicyclo [2.2.2] oct-5-ene and its derivatives
ZA201400102B (en) Devices and methods for emanating liquids
HK1204937A1 (en) Pharmaceutical composition comprising (1r,4r)-6-fluoro-n,n-dimethyl- 4-phenyl-4,9-dihydro-3h-spiro[cyclohexane-1,1-pyrano [3,4,b]indol]-4-amine and an anticonvulsant (1r4r)-6--nn--4--49--3h-[- 11-[34b]]-4-
EP2757601A4 (en) LIGHT EMITTING APPARATUS AND LIGHTING APPARATUS PROVIDED WITH SAID LIGHT EMITTING APPARATUS
EP2640397A4 (en) METHODS OF TREATING FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME
ZA201400187B (en) Suspension device and seasoning
LT2849745T (lt) Farmacinė kompozicija, apimanti (1r,4r)-6'-fluor-n,n-dimetil-4-fenil-4',9'-dihidro-3'h-spiro[cikloheksan-1,1'-pirano-[3,4,b]indol]-4-aminą ir ibuprofeną
EP2872166A4 (en) COMPOSITIONS AND METHODS OF DETECTING, TREATING AND PREVENTING ILLNESSES AND DISORDERS
GB201211223D0 (en) Devices and methods for emanating liquids
HK1204943A1 (en) Pharmaceutical composition comprising (1r,4r)-6-fluoro-n,n-dimethyl- 4-phenyl-4,9-dihydro-3h-spiro[cyclohexane-1,1-pyrano [3,4,b]indol]-4-amine and a gabapentinoid (1r4r)-6--nn--4--49--3h-[-1 1-[34b]]-4-
LT2809320T (lt) (1r,4r)-6`-fluor-(n-metil- arba n,n-dimetil-)-4-fenil-4`,9`-dihidro-3`h-spiro-[cikloheksan-1,1`-pirano[3,4,b]indol]-4-aminas fibromialgijos ir lėtinio nuovargio sindromo gydymui
GB2492154B (en) Devices and methods for emanating liquids
ZA201404986B (en) Methods for preventing, treating or diagnosing disorders
LT2849747T (lt) Farmacinė kompozicija, apimanti (1r,4r)-6`-fluor-n,n-dimetil-4-fenil-4`,9`-dihidro-3`h-spiro[cikloheksan-1,1`-pirano [3,4,b]indol]-4-aminą ir nsar
GB201211212D0 (en) Devices and methods for emanating liquids
HK1204944A1 (en) Pharmaceutical composition comprising (1r,4r)-6-fluoro-n,n-dimethyl- 4-phenyl-4,9-dihydro-3h-spiro[cyclohexane-1,1-pyrano [3,4,b]indol]-4-amine and antidepressants (1r4r)-6--nn--4--49--3h-[- 11-[34b]]-4-